ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

123
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
21 Oct 2019 12:15

HK Connect Flows: Finally the Inclusion for Xiaomi/Meituan

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
437 Views
Share
bullishXiaomi
07 Oct 2019 09:20

Hong Kong Buyback Weekly: Xiaomi Led the Buybacks (2019-10-04)

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
474 Views
Share
19 Aug 2019 13:59

HK Connect Ideas: Highlight of Hang Seng Quarterly Review (2019-08-16)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
584 Views
Share
bullishTencent
12 Aug 2019 11:10

HK Connect Ideas: Tencent Newsflow Before Earnings, Strong Southbound Flows (2019-08-09)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
557 Views
Share
22 Jul 2019 11:39

HK Connect Ideas: Ten Weeks of Inflows, Sino Biopharm, Anta, Maoyan, H&H (2019-07-19)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
501 Views
Share
x